Searched over 200M research papers
4 papers analyzed
These studies suggest that metformin is not only used for glucose metabolism in PCOS and gestational diabetes but also shows potential as an alternative treatment for conditions like hyperandrogenism, hirsutism, spinal cord injury, and chronic pain with associated mental health issues.
20 papers analyzed
Metformin is a widely used antihyperglycemic drug primarily prescribed for managing type 2 diabetes. It has been shown to improve glucose metabolism and has various other health benefits, including potential effects on chronic pain and polycystic ovary syndrome (PCOS) . However, there is growing interest in exploring alternative treatments that can offer similar benefits.
In the treatment of PCOS, metformin has been compared to oral contraceptive pills like ethinyl estradiol-cyproterone acetate. Metformin has been found to significantly decrease waist-to-hip ratio, serum testosterone, fasting free fatty acid, and insulin concentrations. It also improves oxidative glucose utilization and menstrual cyclicity. These effects make metformin a useful alternative for managing PCOS, especially in obese, anovulatory women.
Oral contraceptives, such as Diane Nova, have also been effective in reducing serum testosterone and increasing sex hormone-binding globulin concentrations. However, they may slightly worsen glucose tolerance, making metformin a preferable option for some women.
Metformin is increasingly being used as an alternative to insulin for treating gestational diabetes mellitus (GDM). Studies have shown that neonates born to metformin-treated mothers tend to have lower birth weights and ponderal indices compared to those born to insulin-treated mothers. However, these children may experience accelerated postnatal growth, resulting in higher BMI by mid-childhood. This suggests that while metformin is effective during pregnancy, its long-term effects on child growth need further investigation.
Metformin has shown promise in managing chronic pain conditions, including neuropathic pain and pain associated with spinal cord injuries. Its anti-inflammatory and neuroprotective properties help reduce neuroinflammation and improve locomotor recovery . These effects are comparable to those of minocycline, another anti-neuroinflammatory therapy.
The beneficial effects of metformin in chronic pain are believed to be mediated through the activation of AMP-activated protein kinase (AMPK), which inhibits the mechanistic target of rapamycin complex 1 (mTORC1). This pathway reduces neuronal plasticity and has been linked to the drug's antinociceptive effects. Metformin has also been shown to alleviate anxiety, depression, and cognitive impairment associated with chronic pain in animal models.
Metformin is a versatile drug with applications beyond its primary use in diabetes management. It offers significant benefits in treating PCOS and GDM and shows promise as an alternative therapy for chronic pain. However, the long-term effects, especially in children exposed to metformin in utero, warrant further research. As the search for effective alternative treatments continues, metformin remains a valuable option in various medical conditions.
Most relevant research papers on this topic